Search Results

There are 29977 results for: content related to: Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy

  1. Rosiglitazone for type 2 diabetes mellitus

    Intervention Review

    The Cochrane Library

    Bernd Richter, Elizabeth Bandeira-Echtler, Karla Bergerhoff, Christine Clar and Susanne H Ebrahim

    Published Online : 18 JUL 2007, DOI: 10.1002/14651858.CD006063.pub2

  2. Regulation of adipose triglyceride lipase by rosiglitazone

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 2, February 2009, Pages: 131–142, L.-F. Liu, A. Purushotham, A. A. Wendel, K. Koba, J. DeIuliis, K Lee and M. A. Belury

    Version of Record online : 17 JUL 2008, DOI: 10.1111/j.1463-1326.2008.00916.x

  3. You have free access to this content
    Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone

    Journal of Neurochemistry

    Volume 97, Issue 2, April 2006, Pages: 435–448, Yumin Luo, Wei Yin, Armando P. Signore, Feng Zhang, Zhen Hong, Suping Wang, Steven H. Graham and Jun Chen

    Version of Record online : 15 MAR 2006, DOI: 10.1111/j.1471-4159.2006.03758.x

  4. You have full text access to this OnlineOpen article
    Effects of icosapent ethyl (Eicosapentaenoic acid ethyl ester) on pharmacokinetic parameters of rosiglitazone in healthy subjects

    Clinical Pharmacology in Drug Development

    Volume 4, Issue 2, March/April 2015, Pages: 143–148, Rene A. Braeckman, William G. Stirtan and Paresh N. Soni

    Version of Record online : 3 DEC 2014, DOI: 10.1002/cpdd.150

  5. You have free access to this content
    Rosiglitazone selectively inhibits KATP channels by acting on the KIR6 subunit

    British Journal of Pharmacology

    Volume 167, Issue 1, September 2012, Pages: 26–36, Lei Yu, Xin Jin, Ningren Cui, Yang Wu, Zhenda Shi, Daling Zhu and Chun Jiang

    Version of Record online : 3 AUG 2012, DOI: 10.1111/j.1476-5381.2012.01934.x

  6. You have free access to this content
    Rosiglitazone inhibits Kv4.3 potassium channels by open-channel block and acceleration of closed-state inactivation

    British Journal of Pharmacology

    Volume 163, Issue 3, June 2011, Pages: 510–520, I Jeong, BH Choi and SJ Hahn

    Version of Record online : 11 MAY 2011, DOI: 10.1111/j.1476-5381.2011.01210.x

  7. Cardiovascular risk and thiazolidinediones—what do meta-analyses really tell us?

    Diabetes, Obesity and Metabolism

    Volume 12, Issue 12, December 2010, Pages: 1023–1035, G. Schernthaner and R. J. Chilton

    Version of Record online : 12 JUL 2010, DOI: 10.1111/j.1463-1326.2010.01262.x

  8. A Review of Rosiglitazone in Type 2 Diabetes Mellitus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 21, Issue 9, September 2001, Pages: 1082–1099, Amy L. Werner and Maryann T. Travaglini

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.21.13.1082.34615

  9. You have free access to this content
    Effects of rosiglitazone on the configuration of action potentials and ion currents in canine ventricular cells

    British Journal of Pharmacology

    Volume 163, Issue 3, June 2011, Pages: 499–509, N Szentandrássy, G Harmati, L Bárándi, J Simkó, B Horváth, J Magyar, T Bányász, I Lőrincz, A Szebeni, V Kecskeméti and PP Nánási

    Version of Record online : 11 MAY 2011, DOI: 10.1111/j.1476-5381.2011.01215.x

  10. You have free access to this content
    Rosiglitazone-activated PPARγ induces neurotrophic factor-α1 transcription contributing to neuroprotection

    Journal of Neurochemistry

    Volume 134, Issue 3, August 2015, Pages: 463–470, Erwan Thouennon, Yong Cheng, Vida Falahatian, Niamh X. Cawley and Yoke Peng Loh

    Version of Record online : 1 JUN 2015, DOI: 10.1111/jnc.13152

  11. Preserved Response to Diuretics in Rosiglitazone-Treated Subjects With Insulin Resistance: A Randomized Double-Blind Placebo-Controlled Crossover Study

    Clinical Pharmacology & Therapeutics

    Volume 89, Issue 4, April 2011, Pages: 587–594, AJ Rennings, FG Russel, Y Li, PM Deen, R Masereeuw, CJ Tack and P Smits

    Version of Record online : 2 MAR 2011, DOI: 10.1038/clpt.2010.360

  12. You have free access to this content
    Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone

    British Journal of Clinical Pharmacology

    Volume 48, Issue 3, September 1999, Pages: 424–432, Baldwin, Clarke and Chenery

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.1999.00030.x

  13. Anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway

    Cell Biology International

    Volume 36, Issue 3, March 2012, Pages: 305–310, Jung-Sun Kim, Il-Kwon Kim, Se-Yeon Lee, Byeong-Wook Song, Min-Ji Cha, Heesang Song, Eunmi Choi, Soyeon Lim, Onju Ham, Yangsoo Jang and Ki-Chul Hwang

    Version of Record online : 2 JAN 2013, DOI: 10.1042/CBI20100524

  14. Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study

    Diabetes, Obesity and Metabolism

    Volume 1, Issue 3, May 1999, Pages: 165–172, J. Patel, R. J. Anderson and E. B. Rappaport

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1463-1326.1999.00020.x

  15. You have free access to this content
    Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12-month randomized, prospective, open- label trial

    Hepatology

    Volume 54, Issue 5, November 2011, Pages: 1631–1639, Dawn M. Torres, Frances J. Jones, Janet C. Shaw, Christopher D. Williams, John A. Ward and Stephen A. Harrison

    Version of Record online : 28 OCT 2011, DOI: 10.1002/hep.24558

  16. Long-term 2-year safety and efficacy of vildagliptin compared with rosiglitazone in drug-naïve patients with type 2 diabetes mellitus

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 6, June 2009, Pages: 571–578, J. Rosenstock, M. Niggli and M. Maldonado-Lutomirsky

    Version of Record online : 5 APR 2009, DOI: 10.1111/j.1463-1326.2008.01021.x

  17. You have free access to this content
    Loss of XIAP sensitizes rosiglitazone-induced growth inhibition of colon cancer in vivo

    International Journal of Cancer

    Volume 122, Issue 12, 15 June 2008, Pages: 2858–2863, Yun Dai, Liang Qiao, Kwok Wah Chan, Bing Zou, Juan Ma, Hui Y. Lan, Qing Gu, Zesong Li, Yan Wang, Benny L.W. Wong and Benjamin C.Y. Wong

    Version of Record online : 19 MAR 2008, DOI: 10.1002/ijc.23443

  18. Phase I clinical trial of oral rosiglitazone in combination with intravenous carboplatin in cancer-bearing dogs

    Veterinary and Comparative Oncology

    Volume 12, Issue 1, March 2014, Pages: 1–9, S. Allstadt Frazier, D. S. McKemie, T. A. Guerrero, H. LaChapelle, K. A. Skorupski, P. H. Kass and C. O. Rodriguez Jr

    Version of Record online : 24 FEB 2012, DOI: 10.1111/j.1476-5829.2012.00322.x

  19. Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes

    Diabetes, Obesity and Metabolism

    Volume 10, Issue 10, October 2008, Pages: 959–969, R. Scott, T. Loeys, M. J. Davies, S. S. Engel and for the Sitagliptin Study 801 Group

    Version of Record online : 14 JAN 2008, DOI: 10.1111/j.1463-1326.2007.00839.x

  20. Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 10, October 2015, Pages: 1026–1035, Jason C. Hsu, Ching-Lan Cheng, Dennis Ross-Degnan, Anita K. Wagner, Fang Zhang, Yea-Huei Kao Yang, Li-Ling Liu, Hsueh-Yung Tai, Ke-Hsin Chen, Po-Wen Yang and Christine Y. Lu

    Version of Record online : 6 AUG 2015, DOI: 10.1002/pds.3834